Skip to main content

Table 4 The influence of medical specialist prescribing on the average number of days (SD) to the GP's first prescription for a new drug in the first six months after market introduction.

From: Is new drug prescribing in primary care specialist induced?

  GPs starting therapy before repeating a specialist prescription GPs starting therapy after repeating a specialist prescription  
  N Mean days (SD) N Mean days (SD) Pearson Chi-square
Salmeterol/fluticasone 23 (67.6%) 88.6 (36.3) 11 (32.4%) 109.0 (41.3) 0.69
Rofecoxib 28 (50.9%) 71.7 (56.1) 27 (49.1%) 87.8 (42.5) 0.56
Esomeprazole 19 (70.4%) 53.8 (43.8) 8 (29.6%) 87.3 (48.9) 0.56
Tiotropium 26 (40.0%) 45.0 (46.5) 39 (60.0%) 88.0 (52.7) 0.60
Rosuvastatin 23 (67.6%) 43.1 (40.1) 11 (32.4%) 108.8 (48.1) 0.34